Place · Level 3 · Supplement
Glutathione (GSH)
身体自造的三肽 · 半胱氨酸是限速原料 · 这就是为什么 NAC / 甘氨酸 / α-硫辛酸站得住、口服 GSH 生物利用度差 · IV 美白排毒抗衰宣称证据薄
Story path
- 1Identity · a body-made tripeptideIdentity · a body-made tripeptide
- 2Mechanism · the redox cycleMechanism · the redox cycle
- 3Site · liver Phase II detoxSite · liver Phase II detox
- 4Mechanism · oral GSH bioavailabilityMechanism · oral GSH bioavailability
- 5The real levers · precursors & recyclersThe real levers · precursors & recyclers
- 6Marketing vs evidenceMarketing vs evidence
Chapter 1
Identity · a body-made tripeptide
Identity · a body-made tripeptide
Inside almost every cell in your body, in the cell fluid (the cytosol), there is a self-made antioxidant molecule called glutathione (GSH). It is the most abundant low-molecular-weight thiol antioxidant in the cell — the body's first built-in line of defense against oxidative waste.
The first key point: the body synthesizes it itself — you don't have to eat it whole from food. It is a short chain of three amino acids strung together — a molecule of three linked amino acids is called a tripeptide:
Glutamate (Glu) — generally not scarceCysteine (Cys) — often insufficient, and the rate-limiting raw materialGlycine (Gly) — generally not scarce
Of the three, only cysteine is the bottleneck: it is relatively scarce in the diet, and it is heavily consumed the moment the cell faces oxidative stress or a detox task. The first synthesis enzyme, GCL (glutamate-cysteine ligase), is the rate-limiting valve of the whole pathway, and how fast it works is dictated by the cysteine concentration inside the cell.
This single fact goes on to explain almost every marketing truth-or-myth about glutathione: whoever can reliably supply cysteine is what actually decides how much GSH the cell can make. So remember one sentence — glutathione is not a scarce substance you top up from outside; it is a body-built, raw-material-driven synthesis system.
The first key point: the body synthesizes it itself — you don't have to eat it whole from food. It is a short chain of three amino acids strung together — a molecule of three linked amino acids is called a tripeptide:
Glutamate (Glu) — generally not scarceCysteine (Cys) — often insufficient, and the rate-limiting raw materialGlycine (Gly) — generally not scarce
Of the three, only cysteine is the bottleneck: it is relatively scarce in the diet, and it is heavily consumed the moment the cell faces oxidative stress or a detox task. The first synthesis enzyme, GCL (glutamate-cysteine ligase), is the rate-limiting valve of the whole pathway, and how fast it works is dictated by the cysteine concentration inside the cell.
This single fact goes on to explain almost every marketing truth-or-myth about glutathione: whoever can reliably supply cysteine is what actually decides how much GSH the cell can make. So remember one sentence — glutathione is not a scarce substance you top up from outside; it is a body-built, raw-material-driven synthesis system.
Chapter 2
Mechanism · the redox cycle
Mechanism · the redox cycle
Glutathione inside the cell is not spent once and discarded — it keeps running a loop: made, sent out to neutralize waste, then repaired back to its original form, over and over.
Where it works — clearing peroxides: in the cytosol, in mitochondria, and especially inside red blood cells, an enzyme called glutathione peroxidase (GPx) leads the job, using GSH to neutralize hydrogen peroxide and lipid peroxides — the membrane-damaging oxidative waste. Red blood cells shuttle oxygen all day in a high-oxygen environment and are most vulnerable to oxidative damage, so they lean especially hard on this GSH/GPx system. Incidentally, GPx is a selenium-containing enzyme — which is why selenium and glutathione's antioxidant capacity are often discussed together.
After neutralizing, it must be repaired: while neutralizing waste, GSH is itself oxidized into its used form, GSSG (the oxidized dimer). Then glutathione reductase (GR) repairs GSSG back into fresh GSH, a repair that burns NADPH.
NADPH comes from the pentose phosphate pathway of glucose, whose key enzyme is G6PD. So the whole antioxidant loop indirectly depends on your glucose metabolism — which is why people with G6PD deficiency (more common in Mediterranean, Middle Eastern, African, and Southeast Asian ancestry) have red cells more prone to oxidative hemolysis. This G6PD caveat is covered in more detail in the neighboring NAC entry.
Where it works — clearing peroxides: in the cytosol, in mitochondria, and especially inside red blood cells, an enzyme called glutathione peroxidase (GPx) leads the job, using GSH to neutralize hydrogen peroxide and lipid peroxides — the membrane-damaging oxidative waste. Red blood cells shuttle oxygen all day in a high-oxygen environment and are most vulnerable to oxidative damage, so they lean especially hard on this GSH/GPx system. Incidentally, GPx is a selenium-containing enzyme — which is why selenium and glutathione's antioxidant capacity are often discussed together.
After neutralizing, it must be repaired: while neutralizing waste, GSH is itself oxidized into its used form, GSSG (the oxidized dimer). Then glutathione reductase (GR) repairs GSSG back into fresh GSH, a repair that burns NADPH.
NADPH comes from the pentose phosphate pathway of glucose, whose key enzyme is G6PD. So the whole antioxidant loop indirectly depends on your glucose metabolism — which is why people with G6PD deficiency (more common in Mediterranean, Middle Eastern, African, and Southeast Asian ancestry) have red cells more prone to oxidative hemolysis. This G6PD caveat is covered in more detail in the neighboring NAC entry.
Site · why red cells are the front line
Naming the site of action is what keeps glutathione from being treated as a vague whole-body antioxidant magic:Red blood cells: no nucleus, no mitochondria, limited repair capacity, yet working all day at the highest oxygen tension → the GSH pool is central to resisting oxidative damage and keeping hemoglobin from being oxidized (into methemoglobin).Mitochondria: leak reactive oxygen while generating energy, and their own GSH share puts out the fire on the spot.Liver: the main battlefield of detox conjugation — covered in the next scene.
In one line: glutathione is not an antioxidant spray applied evenly over the whole body; it is a local defense maintained separately at each high-oxidative-stress site. Once you grasp this, claims like "one shot for whole-body antioxidant protection" trigger an instinctive skepticism.
Chapter 3
Site · liver Phase II detox
Site · liver Phase II detox
Glutathione's most misunderstood identity is detox. The truth: detox is not the mystical "washing the blood clean" — it is a very specific chemical conjugation reaction in the liver.
Handling foreign toxins and drugs in the liver runs in two shifts. The second shift is called Phase II conjugation: a family of enzymes called glutathione S-transferases (GST) attach GSH onto reactive, electrophilic toxins that would otherwise stick indiscriminately to cell components, giving them a water-soluble tag → making them easy to excrete → cleared via bile or urine. This is what "detox" actually looks like biochemically: conjugate, solubilize, excrete.
The classic example is paracetamol (acetaminophen) overdose: the drug is converted in the liver into a highly toxic intermediate, NAPQI. At normal doses the hepatocyte's GSH neutralizes it instantly — no harm. But in overdose, NAPQI keeps being generated → the GSH pool runs out → unbound NAPQI covalently binds liver proteins → massive hepatocyte necrosis. This is why paracetamol overdose is a rescue-level emergency, and the antidote is precisely to rapidly rebuild the GSH pool by supplying the cysteine precursor — the very logic covered in the neighboring NAC entry.
Handling foreign toxins and drugs in the liver runs in two shifts. The second shift is called Phase II conjugation: a family of enzymes called glutathione S-transferases (GST) attach GSH onto reactive, electrophilic toxins that would otherwise stick indiscriminately to cell components, giving them a water-soluble tag → making them easy to excrete → cleared via bile or urine. This is what "detox" actually looks like biochemically: conjugate, solubilize, excrete.
The classic example is paracetamol (acetaminophen) overdose: the drug is converted in the liver into a highly toxic intermediate, NAPQI. At normal doses the hepatocyte's GSH neutralizes it instantly — no harm. But in overdose, NAPQI keeps being generated → the GSH pool runs out → unbound NAPQI covalently binds liver proteins → massive hepatocyte necrosis. This is why paracetamol overdose is a rescue-level emergency, and the antidote is precisely to rapidly rebuild the GSH pool by supplying the cysteine precursor — the very logic covered in the neighboring NAC entry.
Unpacking the word 'detox'
The "glutathione detox" sold on the market is almost always deliberately vague. Unpacked:What it does: in the liver, GST conjugates specific electrophilic toxins / certain drug metabolites and excretes them. This is a concrete reaction with an enzyme, a substrate, and a product.What it does not do: there is no evidence that a shot or a capsule of GSH "washes out" the so-called "accumulated toxins" in your blood — that narrative has no clearly defined "toxin" and no hard-endpoint studies behind it.
So when someone says "glutathione helps you detox," the right follow-up is: detox which specific molecule? Through which enzyme? Is there human endpoint data? Most marketing fails all three. If you genuinely want to help the liver's Phase II system, it comes from not overloading it (less alcohol, careful not to overdose paracetamol) — not from buying an extra bottle.
Chapter 4
Mechanism · oral GSH bioavailability
Mechanism · oral GSH bioavailability
If GSH is so important, why not just swallow a reduced-glutathione capsule? Here the wording has to be precise — no crude oversimplification.
Single dose: barely enters the blood. GSH is a tripeptide; in the gut it is largely cut back into three free amino acids by peptidases on the intestinal wall (especially γ-glutamyltransferase). A human study gave healthy volunteers a single 3 g oral dose of glutathione, after which plasma GSH concentration did not rise significantly, concluding that the systemic availability of a single oral dose is negligible.
Long-term use: modestly raises stores, but look closely at how. A 6-month randomized controlled trial (250 or 1000 mg/day) showed that chronic oral GSH did raise body stores in blood, erythrocytes, plasma, and lymphocytes (about +30–35% in the high-dose group). But note two things: first, this looks more like GSH being broken into amino acids, absorbed, and re-synthesized inside the body — a round trip whose bottleneck is still that cysteine raw material; second, higher stores ≠ curing a disease — that study measured body stores, not any disease endpoint.
So the honest conclusion: oral GSH is not a "completely useless" scam, but it is expensive (often 2–5× the price of NAC), barely enters the blood in a single dose, and even long-term only feeds the raw material into the synthesis system by a roundabout route. To raise the GSH pool, supplying the cysteine precursor directly is more direct, cheaper, and more controllable — which is exactly the star of the next scene.
Single dose: barely enters the blood. GSH is a tripeptide; in the gut it is largely cut back into three free amino acids by peptidases on the intestinal wall (especially γ-glutamyltransferase). A human study gave healthy volunteers a single 3 g oral dose of glutathione, after which plasma GSH concentration did not rise significantly, concluding that the systemic availability of a single oral dose is negligible.
Long-term use: modestly raises stores, but look closely at how. A 6-month randomized controlled trial (250 or 1000 mg/day) showed that chronic oral GSH did raise body stores in blood, erythrocytes, plasma, and lymphocytes (about +30–35% in the high-dose group). But note two things: first, this looks more like GSH being broken into amino acids, absorbed, and re-synthesized inside the body — a round trip whose bottleneck is still that cysteine raw material; second, higher stores ≠ curing a disease — that study measured body stores, not any disease endpoint.
So the honest conclusion: oral GSH is not a "completely useless" scam, but it is expensive (often 2–5× the price of NAC), barely enters the blood in a single dose, and even long-term only feeds the raw material into the synthesis system by a roundabout route. To raise the GSH pool, supplying the cysteine precursor directly is more direct, cheaper, and more controllable — which is exactly the star of the next scene.
Chapter 5
The real levers · precursors & recyclers
The real levers · precursors & recyclers
Connecting the previous scenes yields a counterintuitive but defensible principle: to support the GSH system, don't eat GSH — feed its rate-limiting raw material and help its recycling step. There are three levers of differing evidence weight:
1. NAC (N-acetylcysteine) — supplies cysteine. It is a stabilized form of the rate-limiting raw material cysteine wearing a protective coat; inside the cell it releases cysteine and eases the GCL rate-limiting valve. NAC is an FDA-approved real drug for paracetamol overdose (grade A) — details in the neighboring NAC entry.
2. Glycine — supplies the third amino acid. Studies have combined glycine with NAC (together called GlyNAC) in older adults: a 16-week small randomized trial showed it raised the older adults' lowered red-cell and muscle GSH and improved several oxidative-stress and aging-related markers. But this is early evidence with a very small sample that needs larger replication — it cannot be treated as a proven anti-aging protocol. Glycine has several other roles in the body; see the neighboring glycine entry.
3. Alpha-lipoic acid (ALA) — helps recycling. Sources indicate that ALA's reduced form (DHLA) can help regenerate used GSSG back into fresh GSH — it works on the recycling step rather than supplying raw material. This is a mechanistic action; see the neighboring alpha-lipoic acid entry.
The common thread: all three act on a real biochemical step of making or repairing GSH, so the logic is self-consistent; whereas oral GSH tries to skip the whole synthesis system and air-drop the finished product — which is precisely the least mechanism-consistent approach.
1. NAC (N-acetylcysteine) — supplies cysteine. It is a stabilized form of the rate-limiting raw material cysteine wearing a protective coat; inside the cell it releases cysteine and eases the GCL rate-limiting valve. NAC is an FDA-approved real drug for paracetamol overdose (grade A) — details in the neighboring NAC entry.
2. Glycine — supplies the third amino acid. Studies have combined glycine with NAC (together called GlyNAC) in older adults: a 16-week small randomized trial showed it raised the older adults' lowered red-cell and muscle GSH and improved several oxidative-stress and aging-related markers. But this is early evidence with a very small sample that needs larger replication — it cannot be treated as a proven anti-aging protocol. Glycine has several other roles in the body; see the neighboring glycine entry.
3. Alpha-lipoic acid (ALA) — helps recycling. Sources indicate that ALA's reduced form (DHLA) can help regenerate used GSSG back into fresh GSH — it works on the recycling step rather than supplying raw material. This is a mechanistic action; see the neighboring alpha-lipoic acid entry.
The common thread: all three act on a real biochemical step of making or repairing GSH, so the logic is self-consistent; whereas oral GSH tries to skip the whole synthesis system and air-drop the finished product — which is precisely the least mechanism-consistent approach.
Chapter 6
Marketing vs evidence
Marketing vs evidence
Glutathione is packaged as "universal" through three big claims; let's check each against the evidence:
1. IV skin whitening. Mechanistically GSH can indeed inhibit melanin synthesis (inhibiting tyrosinase and shifting darker eumelanin toward lighter pheomelanin). But human evidence is weak and insufficient and cannot be called "significant" — a review that systematically surveyed this topic states plainly that the depigmentation claims look more like a marketing gimmick of pharma/cosmeceutical companies, with a gap between the existing evidence and safety. There are also safety red flags: the review notes that the Philippine drug regulator issued an advisory on intravenous glutathione for whitening, citing reports of serious skin reactions (such as Stevens-Johnson syndrome) and thyroid dysfunction.
2. IV / oral detox. Already clarified above: GSH's detox is a concrete GST conjugation reaction in the liver, not "washing the blood." "A shot to detox" has no rigorous disease-endpoint evidence.
3. Oral anti-aging. The evidence today stops at "modestly raising body GSH stores" (Richie 2015) and "a small GlyNAC RCT improving several aging markers" (Kumar 2023) — both surrogate markers or early signals, not hard clinical endpoints, and certainly not to be written as "significant anti-aging."
The practical approach: to support your own GSH system, the priorities are — don't smoke, drink less (the largest source of oxidative stress), sleep enough, and eat enough sulfur-amino-acid-rich whole foods (eggs, fish, cruciferous vegetables provide the cysteine raw material); consider NAC only under a doctor's guidance for a specific indication like paracetamol antidote or COPD; and don't pay for "IV whitening / detox."
This page is educational and does not replace a physician; for any intravenous procedure, seek evaluation from a qualified medical facility.
1. IV skin whitening. Mechanistically GSH can indeed inhibit melanin synthesis (inhibiting tyrosinase and shifting darker eumelanin toward lighter pheomelanin). But human evidence is weak and insufficient and cannot be called "significant" — a review that systematically surveyed this topic states plainly that the depigmentation claims look more like a marketing gimmick of pharma/cosmeceutical companies, with a gap between the existing evidence and safety. There are also safety red flags: the review notes that the Philippine drug regulator issued an advisory on intravenous glutathione for whitening, citing reports of serious skin reactions (such as Stevens-Johnson syndrome) and thyroid dysfunction.
2. IV / oral detox. Already clarified above: GSH's detox is a concrete GST conjugation reaction in the liver, not "washing the blood." "A shot to detox" has no rigorous disease-endpoint evidence.
3. Oral anti-aging. The evidence today stops at "modestly raising body GSH stores" (Richie 2015) and "a small GlyNAC RCT improving several aging markers" (Kumar 2023) — both surrogate markers or early signals, not hard clinical endpoints, and certainly not to be written as "significant anti-aging."
The practical approach: to support your own GSH system, the priorities are — don't smoke, drink less (the largest source of oxidative stress), sleep enough, and eat enough sulfur-amino-acid-rich whole foods (eggs, fish, cruciferous vegetables provide the cysteine raw material); consider NAC only under a doctor's guidance for a specific indication like paracetamol antidote or COPD; and don't pay for "IV whitening / detox."
This page is educational and does not replace a physician; for any intravenous procedure, seek evaluation from a qualified medical facility.
Red flag · IV glutathione safety
Set the whitening claims aside and look purely at safety:Intravenous glutathione used for whitening is often off-label, high-dose, and repeatedly injected over courses, with a lack of long-term safety data.Adverse reports compiled by the review include: serious skin/mucosal reactions (Stevens-Johnson syndrome / toxic epidermal necrolysis), thyroid dysfunction, and injection-related infection risk; it is precisely for this reason that a national drug regulator issued an advisory.
Judgment principle: something being "mechanistically plausible" does not mean "using it this way is safe and effective." Taking an oral-grade, intracellular antioxidant molecule and injecting it at high dose intravenously for cosmetics is a textbook case of "over-extrapolating the mechanism." If you are considering such a procedure, this page exists to make you ask one more question: where is the evidence, who monitors it, and who is accountable if something goes wrong.